president trump glp 1 Donald announced Thursday a deal with drugmakers Novo Nordisk and Eli Lilly to lower the cost of the GLP-1 weight-loss drugs Wegovy and Zepbound., The deal will expand access for those GLP-1 price reduction: President Trump

This comprehensive review synthesizes current evidence on the mechanisms, established ...

Click for this HIMS stock update.

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options to reach the market and help address a shortage.

GLP-1 agonists market report provides insights for patient pool, challenges, drugs and future market trends in the 7MM

Unlock the best foods to eat on GLP-1 therapies for improved weight management and enhanced health with nutrient-dense options.

A study of nearly 1.1 million people found that semaglutide (the drug in Ozempic and Wegovy) was associated with a 40-70% lower risk of developing Alzheimer's compared to other diabetes medications